Gilead Sciences (GILD) Cash from Financing Activities (2009 - 2026)
Gilead Sciences' Cash from Financing Activities came in at $2.34 billion for Q2 2026, compared with -$1.57 billion a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gilead Sciences reported Cash from Financing Activities of -$4.65 billion; for FY2025, it was -$7.75 billion.
- Going back by year, Cash from Financing Activities was -$3.43 billion in FY2024, -$5.13 billion in FY2023, -$6.47 billion in FY2022 and -$8.88 billion in FY2021.
- The Q2 2026 figure represents the highest quarterly Cash from Financing Activities since Q3 2020.
- Business Quant data shows GILD's Cash from Financing Activities at -$4.24 billion (Q1 2026), -$1.26 billion (Q4 2025) and -$1.49 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | -426.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.34 Bn |
| Mar 31, 2026 | -4.24 Bn |
| Dec 31, 2025 | -1.26 Bn |
| Sep 30, 2025 | -1.49 Bn |
| Jun 30, 2025 | -1.57 Bn |
| Mar 31, 2025 | -3.43 Bn |
| Dec 31, 2024 | 2.26 Bn |
| Sep 30, 2024 | -1.38 Bn |
| Jun 30, 2024 | -2.95 Bn |
| Mar 31, 2024 | -1.36 Bn |
| Dec 31, 2023 | -1.10 Bn |
| Sep 30, 2023 | -1.52 Bn |
| Jun 30, 2023 | -1.10 Bn |
| Mar 31, 2023 | -1.41 Bn |
| Dec 31, 2022 | -1.55 Bn |
| Sep 30, 2022 | -2.12 Bn |
| Jun 30, 2022 | -1.00 Bn |
| Mar 31, 2022 | -1.79 Bn |
| Dec 31, 2021 | -1.94 Bn |
| Sep 30, 2021 | -3.53 Bn |
API Access
Gilead Sciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();